<DOC>
	<DOCNO>NCT00490308</DOCNO>
	<brief_summary>To evaluate whether treatment Estradiol supplementation luteal phase improve IVF outcomes Patients undergoing IVF treatment control ovarian hyperstimulation use GnRH analog receive 4 mg estradiol valerate luteal phase.Patient 's followup include E2 progesterone BHCG 14 day embryo transfer vaginal ultrasound day 21 28 embryo transfer</brief_summary>
	<brief_title>The Influence Estradiol Supplementation During Luteal Patients Undergoing IVF Treatment</brief_title>
	<detailed_description>The study include Patients undergoing IVF treatment control ovarian hyperstimulation use daily GnRH analog long protocol , old 18 , .The woman randomise two groups.Both group give vaginal tab natural micronized progesterone ( Uterogestan ) The study group give oral estradiol Valerate 4 mg.Prior treatment , patient sign informed concent . Patients exclude old 40 , systemic illness personal family history thromboembolic event . Follow : Verification pregnancy status hormonal profile carry day fourteen embryo transfer mean serum hCG , P E2 . clinical pregnancy define presence gestational sac ultrasonography day 21 embryo transfer fetal heart evaluate day 28</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>Women treat infertility control ovarian hyperstimulation use daily GnRH agonist Women young 18 old 40 Women systemic disease Women family personal history thromboembolic event</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>luteal</keyword>
	<keyword>phase</keyword>
	<keyword>estradiol</keyword>
	<keyword>pregnancy</keyword>
	<keyword>rate</keyword>
</DOC>